BridgeBio Pharma, Inc. SEC filings BBIO
BridgeBio Pharma, Inc. has 833 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B7 | Filing | Aug 14, 2026 | — |
| S-3ASR | Automatic shelf registration | Jul 24, 2026 | — |
| S-8 | Employee stock plan registration | Jul 24, 2026 | — |
| S-3ASR | Automatic shelf registration | May 8, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2025 | — |
| S-8 | Employee stock plan registration | Aug 1, 2024 | — |
| 424B5 | Prospectus supplement | Mar 6, 2024 | — |
| 424B5 | Prospectus supplement | Mar 4, 2024 | — |
| S-8 | Employee stock plan registration | Jan 5, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 2, 2023 | — |
| S-3ASR | Automatic shelf registration | Jul 26, 2023 | — |
| S-8 | Employee stock plan registration | May 4, 2023 | — |
| S-3ASR | Automatic shelf registration | May 4, 2023 | — |
| 424B5 | Prospectus supplement | Mar 9, 2023 | — |
| 424B5 | Prospectus supplement | Mar 6, 2023 | — |
| S-8 | Employee stock plan registration | Feb 6, 2023 | — |
| S-8 | Employee stock plan registration | Feb 25, 2022 | — |
| 424B7 | Filing | Feb 16, 2021 | — |
| 424B7 | Filing | Feb 11, 2021 | — |
| S-8 | Employee stock plan registration | Jan 25, 2021 | — |
| S-8 | Employee stock plan registration | Jan 25, 2021 | — |
| 424B3 | Prospectus | Dec 15, 2020 | — |
| S-4/A | Filing | Dec 11, 2020 | — |
| S-4 | Registration for a merger or exchange | Nov 6, 2020 | — |
| S-3ASR | Automatic shelf registration | Jul 28, 2020 | — |
| S-3ASR | Automatic shelf registration | Jul 7, 2020 | — |
| S-8 | Employee stock plan registration | Jul 7, 2020 | — |
| S-8 | Employee stock plan registration | Mar 4, 2020 | — |
| S-8 | Employee stock plan registration | Nov 20, 2019 | — |
| S-8 | Employee stock plan registration | Jul 1, 2019 | — |
| 424B4 | Prospectus | Jun 28, 2019 | — |
| S-1MEF | Filing | Jun 26, 2019 | — |
| S-1/A | Amended registration statement | Jun 26, 2019 | — |
| S-1/A | Amended registration statement | Jun 24, 2019 | — |
| S-1/A | Amended registration statement | Jun 17, 2019 | — |
| S-1/A | Amended registration statement | Jun 11, 2019 | — |
| S-1 | Registration statement | May 24, 2019 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1743881
- Former names
- BridgeBio Pharma LLC (until May 16, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.